Advances in diagnosis and therapy of neuroendocrine tumors
Emilio Bajetta(Fondazione Lanza), Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), Laura Catena(Fondazione IRCCS Istituto Nazionale dei Tumori), Roberto Buzzoni(Fondazione IRCCS Istituto Nazionale dei Tumori), Giuseppe Procopio(Fondazione IRCCS Istituto Nazionale dei Tumori), Leonardo Ferrari
Cited by 6
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
|The Lancet|2009|1.4k